Structural dynamics of the cereblon ligand binding domain

Area of Science:

• Biochemistry
• Structural Biology
• Pharmacology

Background:

• Cereblon (CRBN) is a key target for thalidomide and its analogs.
• The thalidomide-binding domain (CULT) is structurally conserved across species.
• Understanding CRBN's dynamics is crucial for drug development.

Purpose of the Study:

• To investigate the conformational flexibility and dynamics of the Cereblon CULT domain.
• To elucidate the structural basis of thalidomide binding and its effects.
• To analyze the impact of a specific mutation on CRBN structure and function.

Main Methods:

• X-ray crystallography of a bacterial Cereblon representative.
• Analysis of protein structure and ligand interactions at atomic resolution (1.2Å).
• In vitro characterization of C-terminal truncation effects.

Main Results:

• Large portions of the CULT domain, including the binding pocket, fold only upon ligand (thalidomide) binding.
• Thalidomide release triggers significant unfolding of the domain in the crystalline state.
• A C-terminal truncation (R419X mutation) impacts CRBN structure and likely causes thalidomide irresponsiveness.

Conclusions:

• Ligand binding induces the active conformation of the Cereblon CULT domain.
• Structural dynamics are critical for Cereblon's interaction with thalidomide.
• The R419X mutation provides insights into CRBN-drug interactions and potential therapeutic resistance.